Оценка структурно-функционального состояния миокарда по данным однофотонной эмиссионной компьютерной томографии в сравнении с другими методами визуализации у больных ишемической болезнью сердца
Диссертация
Проведение ОЭКТ по протоколу покой+нагрузка целесообразно выполнить в случае верификации диагноза ИБС тем больным, у которых результаты клинического обследования, нагрузочной пробы сомнительны, а также в случае многососудистого поражения при решении вопроса о проведении эндоваскулярного лечения для определения объема вмешательства. Проведение ОЭКТ позволяет повысить диагностическую ценность… Читать ещё >
Содержание
- СПИСОК СОКРАЩЕНИЙ
- ВВЕДЕНИЕ: АКТУАЛЬНОСТЬ ПРОБЛЕМЫ
- НАУЧНО-ПРАКТИЧЕСКАЯ ЗНАЧИМОСТ
- ГЛАВА I. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. томографические методы в оценке структурно-функционального состояния миокарда
- 1. 2. МСКТ в диагностике ИБС
- 1. 3. МРТ в диагностике ИБС
- 1. 4. ОЭКТ с ЭКГ-синхронизацией (С-ОЭКТ) в диагностике ИБС
- 1. 5. ПЭТ-КТ и ОЭКТ-КТ в диагностике ИБС
- 1. 6. возможности молекулярной визуализации в диагностике ИБС
- ГЛАВА II. МАТЕРИАЛ И МЕТОДЫ ИССЛЕДОВАНИЯ
- 2. 1. Характеристика обследованных больных
- 2. 2. Методы исследования
- 2. 3. Комплекс томографических методов диагностики
- 2. 4. Протокол ОЭКТ
- 2. 5. Протокол МРТ
- 2. 6. Протокол МСКТ
- 2. 7. Ретроспективный анализ структуры проведенных томографических исследований у больных с разными формами ИБС и другой сердечнососудистой патологией
- 2. 8. Статистическая обработка
- ГЛАВА III. РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ
- 3. 1. Количественные параметры оценки перфузии и сократимости миокарда по данным ОЭКТ и С-ОЭКТ
- 3. 1. 1. Стандартизация параметров перфузии
- 3. 1. 2. Полуколичественная перфузионная ОЭКТ в покое и после нагрузочных проб
- 3. 1. 3. Синхронизированная ОЭКТ в оценке ФВ ЛЖ
- 3. 1. 4. Сопоставление параметров перфузии и сократимости по данным синхронизированной ОЭКТ в покое и после нагрузочных проб
- 3. 2. Сопоставление данных ОЭКТ, КТА и КАГ
- 3. 3. Сопоставление данных МРТ и ОЭКТ в оценке структурного состояния миокарда
- 3. 4. Ретроспективный анализ томографических исследований у больных с разными формами ИБС и с другой сердечно-сосудистой патологией
- 3. 1. Количественные параметры оценки перфузии и сократимости миокарда по данным ОЭКТ и С-ОЭКТ
- ГЛАВА IV. ОБСУЖДЕНИЕ
- ВЫВОДЫ
Список литературы
- Dilsizian, V., et al., Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and18 °F.Jluorodeoxyglucose. Circulation, 1994. 89(2): p. 578−87.
- Gunning, M.G., et al., Hibernating myocardium: clinical and functional response to revascularisation. Eur J Cardiothorac Surg, 1997.11(6): p. 1105−12.
- Чазов, Е.И., ed. Болезни сердца и сосудов Радионуклидные методы исследования, ed. Сергиенко В. Б. and С. Е.Б. Vol. 1. 1992, Медицина: М.
- Vanoverschelde, J.L. and J.A. Melin, The pathophysiology of myocardial hibernation: current controversies and future directions. Prog Cardiovasc Dis, 2001. 43(5): p. 387−98.
- Сергиенко, В.Б., Д.Д. Щербаткин, and А. П. Борисенко, Однофотонная эмиссионная компьютерная томография с 201Т1 в диагностике ишемической болезни сердца Тер. арх., 1985. 4: р. 95−99.
- Piper, Н.М., et al., Sarcoplasmic reticulum-mitochondrial interaction in the mechanism of acute reperfusion injury. Viewpoint. Cardiovasc Res, 2008. 77(2): p. 234−6.
- Rodriguez, N.S., et al., Assessment of ischemia-reperfusion injury and early acute rejection in experimental lung transplantation after prolonged ischemia. Arch Bronconeumol, 2007. 43(7): p. 373−7.
- Thijssen, V.L., et al., Temporal and spatial variations in structural protein expression during the progression from stunned to hibernating myocardium. Circulation, 2004.110(21): p. 3313−21.
- Bonow, R.O., et al., Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med, 2011.364(17): p. 1617−25.
- Deedwania, P.C., The key to unraveling the mystery of mortality in heart failure: an integrated approach. Circulation, 2003. 107(13): p. 1719−21.
- Travin, M.I. and S.R. Bergmann, Assessment of myocardial viability. Semin Nucl Med, 2005. 35(1): p. 2−16.
- Yoshinaga, K. and N. Tamaki, Imaging myocardial metabolism. Curr Opin Biotechnol, 2007. 18(1): p. 52−9.
- Braunwald, E., Expanding indications for beta-blockers in heart failure. N Engl J Med, 2001. 344(22): p. 1711−2.
- Fath-Ordoubadi, F., et al., Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction. Am J Cardiol, 1998. 82(1): p. 26−31.
- Bax, J.J., E.E. van der Wall, and M. Harbinson, Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart, 2004. 90 Suppl 5: p. v26−33.
- D’Egidio, G., et al., Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging, 2009. 2(9): p. 1060−8.
- Ghali, J.K., et al., Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Am Coll Cardiol, 2010. 56(25): p. 2077−80.
- Беленков, Ю.Н. and В. Б. Сергиенко, Роль неинвазивных методов исследования в диагностике атеросклероза. Кардиология, 2007. 47(10): р. 37−44.
- Сергиенко, В.Б., Однофотонная эмиссионная компьютерная томография. Опыт клинического применения Дисс. докт. мед. наук, 1984. М.
- Беленков, Ю.Н. and М. А. Саидова, Оценка жизнеспособности миокарда: клинические аспекты, методы исследования. Кардиология, 1999.1: р. 6−13.
- Braunwald, Е. and R.A. Kloner, The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation, 1982. 66(6): p. 1146−9.
- Rahimtoola, S.H., A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation, 1985. 72(6 Pt 2): p. V123−35.
- Gross, G.J., J.R. Kersten, and D.C. Warltier, Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg, 1999. 68(5): p. 1898−904.
- Bolli, R. and E. Marban, Molecular and cellular mechanisms of myocardial stunning. Physiol Rev, 1999. 79(2): p. 609−34.
- Park, J.L. and B.R. Lucchesi, Mechanisms of myocardial reperfusion injury. Ann Thorac Surg, 1999. 68(5): p. 1905−12.
- Granger, D.N., Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation, 1999. 6(3): p. 167−78.
- Carden, D.L. and D.N. Granger, Pathophysiology of ischaemia-reperfusion injury. J Pathol, 2000. 190(3): p. 255−66.
- Burn, S., M. Walters, and J. Caplin, The hibernating heart: reversible left ventricular dysfunction in chronic heart failure. Postgrad Med J, 1999. 75(885): p. 419−21.
- Ferrari, R., The search for the hibernating myocardium—have we reached the limit? Cardiovasc Drugs Ther, 1999.13(2): p. 137−43.
- Rahimtoola, S.H., Concept and evaluation of hibernating myocardium. Annu Rev Med, 1999. 50: p. 75−86.
- Vanoverschelde, J.L., et al., Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation, 1993. 87(5): p. 1513−23.
- Kloner, R.A., et al., Evidence for stunned myocardium in humans: a 2001 update. Coron Artery Dis, 2001. 12(5): p. 349−56.
- Kloner, R.A. and R.B. Jennings, Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation, 2001.104(24): p. 2981−9.
- Boden, W.E., et al., Incomplete, delayed functional recovery late after reperfusion following acute myocardial infarction: «maimedmyocardium». Am Heart J, 1995.130(4): p. 922−32.
- Schaper, W., Molecular mechanisms in «stunned» myocardium. Cardiovasc Drugs Ther, 1991. 5(5): p. 925−32.
- Opie, L.H., Myocardial stunning—we do not know the mechanism nor is there «overwhelming evidence» for a major role of free radicals. Basic Res Cardiol, 1998. 93(3): p. 152−5.
- Tomai, F., et al., Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation, 1999.100(5): p. 559−63.
- Jenkins, D.P., et al., Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart, 1997. 77(4): p. 314−8.
- Yellon, D.M., et al., Ischaemic preconditioning: present position and future directions. Cardiovasc Res, 1998. 37(1): p. 21−33.
- Miura, Т., et al., Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning? Circulation, 1991. 84(6): p. 2504−12.
- Kuzuya, Т., et al., Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res, 1993. 72(6): p. 1293−9.
- Саидова, M.A., Современные методы диагностики жизнеспособного миокарда. Кардиология, 2005. 9: р. 47−54.
- Heusch, G. and R. Schulz, Features of short-term myocardial hibernation. Mol Cell Biochem, 1998. 186(1−2): p. 185−93.
- Birnbaum, Y. and R.A. Kloner, Myocardial viability. West J Med, 1996.165(6): p. 364−71.
- Chareonthaitawee, P., et al., Viability in chronic ischaemic cardiomyopathy: need for timely revascularisation. EurJNucl Med, 1999.26(11): p. 1521−2.
- Frangogiannis, N.G., The pathological basis of myocardial hibernation. Histol Histopathol, 2003. 18(2): p. 647−55.
- Schulz, R. and G. Heusch, Hibernating myocardium. Heart, 2000. 84(6): p. 587−94.
- Dutka, D.P. and P.G. Camici, Hibernation and congestive heart failure. Heart Fail Rev, 2003. 8(2): p. 167−73.
- Ferrari, R., The new ischemic syndromes—an old phenomenon disguised with a new glossary? Cardiovasc Res, 1997. 36(3): p. 298−300.
- Vanoverschelde, J.L., et al., Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability. Heart, 1999. 82 Suppl 3: p. Ill 1−7.
- Scott, B.D. and R.E. Kerber, Clinical and experimental aspects of myocardial stunning. Prog Cardiovasc Dis, 1992. 35(1): p. 61−76.
- Аронов, Д.М. and В. П. Лупанов, Функциональные пробы в кардиологии. 2007, M.: МЕДпресс-информ.
- Samniah, N. and D. Tzivoni, Assessment of ischemic changes by ambulatory ECG-monitoring: comparison with 12-leadECG during exercise testing. J Electrocardiol, 1997. 30(3): p. 197−204.
- Stone, P.H., et al., Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease. Circulation, 1996. 94(7): p. 1537−44.
- Tzivoni, D., et al., Holter recording during treadmill testing in assessing myocardial ischemic changes. Am J Cardiol, 1985. 55(9): p. 1200−3.
- Gottlieb, S.O., Diagnostic procedures for myocardial ischaemia. Eur Heart J, 1996. 17 Suppl G: p. 53−8.
- Crawford, M.H., et al., Limitations of continuous ambulatory electrocardiogram monitoring for detecting coronary artery disease. Ann Intern Med, 1978. 89(1): p. 1−5.
- Quyyumi, A., et al., The role of ambulatory ST-segment monitoring in the diagnosis of coronary artery disease: comparison with exercise testing and thallium scintigraphy. Eur Heart J, 1987. 8(2): p. 124−9.
- Tzivoni, D., et al., Myocardial ischemia during daily activities and stress. Am J Cardiol, 1986. 58(4): p. 47B-50B.
- Марцевич, С.Ю., Острая боль в груди. Consilium Medicum, 2000. 11(2).
- Саидова, М.А., Стресс-эхокардиография с добутамином: возможности клинического применения в кардиологической практике. Рациональная Фармакотерапия в Кардиологии, 2009. 4: р. 73−79.
- Zwas, D.R., et al., Feasibility of real-time 3-dimensional treadmill stress echocardiography. J Am Soc Echocardiogr, 1999. 12(5): p. 285−9.
- Krenning, B.J., M.M. Voormolen, and J.R. Roelandt, Assessment of left ventricular function by three-dimensional echocardiography. Cardiovasc Ultrasound, 2003. 1: p. 12.
- Zeidan, Z., et al., Analysis of global systolic and diastolic left ventricular performance using volume-time curves by real-time three-dimensional echocardiography. J Am Soc Echocardiogr, 2003. 16(1): p. 29−37.
- Robertson, W.S., et al., Exercise echocardiography: a clinically practical addition in the evaluation of coronary artery disease. J Am Coll Cardiol, 1983. 2(6): p. 1085−91.
- Ашмарин, И.Ю., И.А. Никулин, and B.A. Диденко, Сравнительная ценность проб с нагрузкой для диагностики ишемической болезни на догоспитальном этапе Кардиология, 1990. 4: р. 61−66.
- Elhendy, A., et al., Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol, 1996. 27(2): p. 323−9.
- Шестакова, H.B. and B.A. Шестаков, Методы диагностики преходящей ишемии миокарда у больных ИБС. Русский медицинский журнал, 1999. 6(14): р. 888 894.
- Geleijnse, M.L., et al., Should the diagnosis of coronary artery disease be based on the evaluation of myocardial function or perfusion? Eur Heart J, 1997.18 Suppl D: p. D68−77.
- Al Jaroudi, W. and A.E. Iskandrian, Regadenoson: a new myocardial stress agent. J Am Coll Cardiol, 2009. 54(13): p. 1123−30.
- Ferrari, R., Metabolic disturbances during myocardial ischemia and reperfusion. Am J Cardiol, 1995. 76(6): p. 17B-24B.
- Fallavollita, J.A., et al., Regional alterations in SR Ca (2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol, 1999. 277(4 Pt 2): p. H1418−28.
- Opie, L.H., The ever expanding spectrum of ischemic left ventricular dysfunction. Cardiovasc Drugs Ther, 1994. 8 Suppl 2: p. 297−304.
- Сергиенко, В.Б., Радионуклидные исследования при атеросклерозе. Кардиологический вестник, 2009. IV (2): р. 78−83.
- Терновой, С.К., В.Е. Синицын, and H.B. Гагарина, Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М.: Атмосфера, 2003.
- Терновой, C.K. and В. Е. Синицын, Спиральная компьютерная и электронно-лучевая томография. М.: Видар, 1998.
- Arad, Y., et al., Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol, 2005. 46(1): p. 158−65.
- Berman, D.S., et al., Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol, 2004. 44(4): p. 923−30.
- Berman, D.S., et al., Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: assessment of patients with suspected coronary artery disease. J Nucl Med, 2006. 47(1): p. 74−82.
- Shaw, L.J. and D.S. Berman, Redefining the low-risk patient with significant atherosclerotic disease. J Nucl Cardiol, 2005. 12(4): p. 375−7.
- Raff, G.L., et al., Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. J Am Coll Cardiol, 2005. 46(3): p. 552−7.
- Achenbach, S., et al., Visualization of the coronary arteries in three-dimensional reconstructions using respiratory gated magnetic resonance imaging. Coron Artery Dis, 1997. 8(7): p. 441−8.
- Achenbach, S., et al., Noninvasive, three-dimensional visualization of coronary artery bypass grafts by electron beam tomography. Am J Cardiol, 1997. 79(7): p. 856−61.
- Achenbach, S., et al., Contrast enhanced electron beam computed tomography to analyse the coronary arteries in patients after acute myocardial infarction. Heart, 2000. 84(5): p. 489−93.
- Moshage, W.E., et al., Coronary artery stenoses: three-dimensional imaging with electrocardiographically triggered, contrast agent-enhanced, electron-beam CT. Radiology, 1995. 196(3): p. 707−14.
- Nieman, K., et al., Coronary angiography with multi-slice computed tomography. Lancet, 2001. 357(9256): p. 599−603.
- Achenbach, S., et al., Noninvasive coronary angiography by magnetic resonance imaging, electron-beam computed tomography, and multislice computed tomography. Am J Cardiol, 2001. 88(2A): p. 70E-73E.
- Dirksen, M.S., et al., Cardiac multidetector-row computed tomography in patients with unstable angina. Am J Cardiol, 2005. 95(4): p. 457−61.
- Gerber, T.C., et al., Image quality in a standardized algorithm for minimally invasive coronary angiography with multislice spiral computed tomography. J Comput Assist Tomogr, 2003. 27(1): p. 62−9.
- Leber, A.W., et al., Non-invasive intravenous coronary angiography using electron beam tomography and multislice computed tomography. Heart, 2003. 89(6): p. 633−9.
- Leschka, S., H. Alkadhi, and S. Wildermuth, Images in cardiology. Collateral circulation in aortic coarctation shown by 64 channel multislice computed tomography angiography. Heart, 2005. 91(11): p. 1422.
- Gould, K.L., Does coronary flow trump coronary anatomy? JACC Cardiovasc Imaging, 2009. 2(8): p. 100 923.
- Di Carli, M.F., et al., Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol, 2007.14(6): p. 799−809.
- Hacker, M., et al., Sixty-four slice spiral CT angiography does not predict the functional relevance of coronary artery stenoses in patients with stable angina. Eur J Nucl Med Mol Imaging, 2007. 34(1): p. 4−10.
- Gaemperli, O., et al., Functionally relevant coronary artery disease: comparison of 64-section CT angiography with myocardial perfusion SPECT. Radiology, 2008. 248(2): p. 414−23.
- Rispler, S., et al., Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol, 2007. 49(10): p. 1059−67.
- Gould, K.L., Coronary flow reserve and pharmacologic stress perfusion imaging: beginnings and evolution. JACC Cardiovasc Imaging, 2009. 2(5): p. 664−9.
- King, S.B., 3rd, The COURAGE trial: is there still a role for PCI in stable coronary artery disease? Nat Clin Pract Cardiovasc Med, 2007. 4(8): p. 410−1.
- Asin Cardiel, E. and N. Murga, Current analysis of the results of the COURAGE trial: has an optimal treatment been reached in clinical practice? Am J Cardiovasc Drugs, 2009. 9 Suppl 1: p. 19−21.
- Bhatt, D.L., Interpreting the COURAGE trial. Is medical therapy as good as PCI in stable angina? Two views. Cleve Clin J Med, 2007. 74(9): p. 618, 620.
- Boden, W.E., Interpreting the COURAGE trial. It takes COURAGE to alter our belief system. Cleve Clin J Med, 2007. 74(9): p. 623−5, 629−33.
- Coylewright, M., R.S. Blumenthal, and W. Post, Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease. Mayo Clin Proc, 2008. 83(7): p. 799−805.
- Diamond, G.A. and S. Kaul, COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol, 2007. 50(16): p. 1604−9.
- Fox, K.A., COURAGE to change practice? Revascularisation in patients with stable coronary artery disease. Heart, 2009. 95(9): p. 689−92.
- Franklin, B.A., Lessons learnedfrom the COURAGE trial: generalizability, limitations, and implications. Prev Cardiol, 2007.10(3): p. 117−20.
- Hansen, P.R., COURAGE: guidelines and realities-a comment. Ugeskr Laeger, 2007. 169(23): p. 2228.
- Kakafika, A.I., et al., PCI and stable coronary heart disease—COURAGE to change our minds? Curr Vase Pharmacol, 2007. 5(3): p. 173−4.
- Kereiakes, D.J., Interpreting the COURAGE trial. PCI is no better than medical therapy for stable angina? Seeing is not believing. Cleve Clin J Med, 2007. 74(9): p. 637−8, 640−2.
- Kuller, L.H., Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease. Coron Artery Dis, 2010. 21(7): p. 391−6.
- Maron, D.J., Using COURAGE to treat angina. Medscape J Med, 2008.10(12): p. 286.
- O’Gara, P.T., The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial: can we deliver on its promise? J Am Coll Cardiol, 2010. 55(13): p. 1359−61.
- Tommaso, C.L., One year perspective on COURAGE. Catheter Cardiovasc Interv, 2008. 72(3): p. 426−9.
- Hacker, M., et al., Comparison of spiral multidetector CT angiography and myocardial perfusion imaging in the noninvasive detection of functionally relevant coronary artery lesions: first clinical experiences. J Nucl Med, 2005. 46(8): p. 1294−300.
- George, R.T., et al., Multidetector computed tomography myocardial perfusion imaging during adenosine stress. J Am Coll Cardiol, 2006. 48(1): p. 153−60.
- Tsai, I.C., et al., Comprehensive evaluation of ischemic heart disease using MDCT. AJR Am J Roentgenol, 2008.191(1): p. 64−72.
- Nagao, M., et al., Detection of myocardial ischemia using 64-slice MDCT. Circ J, 2009. 73(5): p. 905−11.
- Bastarrika, G., et al., Adenosine-stress dynamic myocardial CT perfusion imaging: initial clinical experience. Invest Radiol, 2010. 45(6): p. 306−13.
- Nagel, E., et al., Newer methods for noninvasive assessment of myocardial perfusion: cardiac magnetic resonance or cardiac computed tomography? JACC Cardiovasc Imaging, 2009. 2(5): p. 656−60.
- Blankstein, R., I.S. Rogers, and R.C. Cury, Practical tips and tricks in cardiovascular computed tomography: diagnosis of myocardial infarction. J Cardiovasc Comput Tomogr, 2009. 3(2): p. 104−11.
- Blankstein, R., et al., Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol, 2009. 54(12): p. 1072−84.
- Schuleri, K.H., R.T. George, and A.C. Lardo, Applications of cardiac multidetector CT beyond coronary angiography. Nat Rev Cardiol, 2009. 6(11): p. 699−710.
- Ruzsics, В., et al., Comparison of dual-energy computed tomography of the heart with single photon emission computed tomography for assessment of coronary artery stenosis and of the myocardial blood supply. Am J Cardiol, 2009.104(3): p. 318−26.
- Терновой, С.К., et al., Роль мультиспиральной компьютерной томографии в диагностике инфаркта миокарда. Кардиология, 2008. 1.
- Blankstein, R. and M.F. Di Carli, Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol, 2010. 7(4): p. 226−36.
- Miller, J.M., et al., Coronary CT angiography using 64 detector rows: methods and design of the multi-centre trial CORE-64. Eur Radiol, 2009. 19(4): p. 816−28.
- Stacul, F. and H.S. Thomsen, Nonionic monomers and dimers. Eur Radiol, 1996. 6(5): p. 756−61.
- Шимановский, H. JL, Контрастные средства: руководство по рациональному применению. 2009: М.: ГЭОТАР-Медиа.
- Yasuda, R. and Н. Munechika, Delayed adverse reactions to nonionic monomeric contrast-enhanced media. Invest Radiol, 1998. 33(1): p. 1−5.
- Yoshikawa, H., Late adverse reactions to nonionic contrast media. Radiology, 1992.183(3): p. 737−40.
- Sharpies, L., et al., Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess, 2007. 11(49): p. iii-iv, ix-115.
- Балахонова, T.B., et al., Атеросклеротические изменения сонных артерий у больных ишемической болезнью сердца. Визуализация в клинике, 2003. 21: р. 8−12.
- Knight, L.C., Scintigraphic methods for detecting vascular thrombus. J Nucl Med, 1993. 34(3 Suppl): p. 55 461.
- Беленков, Ю.Н., С.К. Терновой, and В.Е. Синицын, Магнитно-резонансная томография сердца и сосудов. Новые методы визуализации в медицине, 1997. М.: ТОО"Видар".
- Kim, W.Y., et al., Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med, 2001.345(26): p. 1863−9.
- Kooi, M.E., et al., Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation, 2003.107(19): p. 2453−8.
- Trivedi, R.A., et al., In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke, 2004. 35(7): p. 1631−5.
- Sirol, M., et al., Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation, 2004.109(23): p. 2890−6.
- Sirol, M., et al., Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging, 2009. 2(5): p. 391−6.
- Barkhausen, J., et al., Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation, 2003.108(5): p. 605−9.
- Meding, J., et al., Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M. Contrast Media Mol Imaging, 2007. 2(3): p. 120−9.
- Ronald, J.A., et al., Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI. Circ Cardiovasc Imaging, 2009. 2(3): p. 226−34.
- Howarth, S., et al., Correlation of macrophage location and plaque stress distribution using USPIO-enhanced MRI in a patient with symptomatic severe carotid stenosis: a new insight into risk stratification. Br J Neurosurg, 2007. 21(4): p. 396−8.
- Lipinski, M.J., et al., MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med, 2006. 56(3): p. 601−10.
- Gustafsson, В., S. Youens, and A.Y. Louie, Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. Bioconjug Chem, 2006. 17(2): p. 538−47.
- Hyafil, F., et al., Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vase Biol, 2006. 26(1): p. 176−81.
- Weber, R., et al., MRI detection of macrophage activity after experimental stroke in rats: new indicators for late appearance of vascular degradation? Magn Reson Med, 2005. 54(1): p. 59−66.
- Jaffer, F.A. and R. Weissleder, Seeing within: molecular imaging of the cardiovascular system. Circ Res, 2004. 94(4): p. 433−45.
- Kim, R.J., et al., Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation, 1999. 100(19): p. 1992−2002.
- McCrohon, J. A., et al., Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 2003. 108(1): p. 54−9.
- Bettencourt, N., et al., Assessment of myocardial ischemia and viability using cardiac magnetic resonance. Curr Heart Fail Rep, 2009. 6(3): p. 142−53.
- Gerber, B.L., et al., Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation, 2002. 106(9): p. 1083−9.
- Gerber, B.L., et al., Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson, 2008. 10: p. 18.
- Bourantas, C.V., et al., Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson, 2011. 13: p. 53.
- Flacke, S.J., S.E. Fischer, and C.H. Lorenz, Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology, 2001.218(3): p. 703−10.
- Kim, R.J., D.J. Shah, and R.M. Judd, How we perform delayed enhancement imaging. J Cardiovasc Magn Reson, 2003. 5(3): p. 505−14.
- Hunold, P., et al., Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol, 2005. 184(5): p. 1420−6.
- Wagner, A., et al., Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet, 2003. 361(9355): p. 374−9.
- Bello, D., et al., Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation, 2003. 108(16): p. 1945−53.
- Kim, R.J., H.B. Hillenbrand, and R.M. Judd, Evaluation of myocardial viability by MRI. Herz, 2000. 25(4): p. 417−30.
- Wu, K.C., et al., Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation, 1998. 97(8): p. 765−72.
- Wellnhofer, E., et al., Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation, 2004. 109(18): p. 2172−4.
- Perrone-Filardi, P., et al., Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol, 1992. 20(1): p. 161−8.
- Nandalur, K.R., et al., Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol, 2007. 50(14): p. 1343−53.
- Tomlinson, D.R., H. Becher, and J.B. Selvanayagam, Assessment of myocardial viability: comparison of echocardiography versus cardiac magnetic resonance imaging in the current era. Heart Lung Circ, 2008. 17(3): p. 17 385.
- Gebker, R., et al., Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology, 2008. 247(1): p. 57−63.
- Kelle, S., et al., Dobutamine stress cardiovascular magnetic resonance at 3 Tesla. J Cardiovasc Magn Reson, 2008.10: p. 44.
- Chung, S.Y., et al., Comparison of stress perfusion MRI and SPЕСТ for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. AJR Am J Roentgenol, 2010. 195(2): p. 356−62.
- Vincenti, G., et al., Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECTto MRI perfusion. J Nucl Cardiol, 2009. 16(4): p. 549−61.
- Vogel-Claussen, J., et al., Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: Comparison with nuclear stress test. J Magn Reson Imaging, 2009. 30(4): p. 753−62.
- Tran, L.A., et al., Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials, 2010. 31(36): p. 9482−91.
- Hassan, A. A., et al., Serine-derivatized gadonanotubes as magnetic nanoprobes for intracellular labeling. Contrast Media Mol Imaging, 2010. 5(1): p. 34−8.
- Hartman, K.B., et al., Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano Lett, 2008. 8(2): p. 415−9.
- Berman, D.S. and R. Hachamovitch, Risk assessment in patients with stable coronary artery disease: incremental value of nuclear imaging. J Nucl Cardiol, 1996. 3(6 Pt 2): p. S41−9.
- Hachamovitch, R. and M.F. Di Carli, Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation, 2008.117(21): p. 2793−801.
- Hachamovitch, R., et al., A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol, 2005. 45(5): p. 722−9.
- Verani, M.S., Thallium-201 single-photon emission computed tomography (SPECT) in the assessment of coronary artery disease. Am J Cardiol, 1992. 70(14): p. 3E-9E.
- Сергиенко, В.Б., et al., Роль дисфункции эндотелия в развитии ишемии миокарда у больных ишемической болезнью сердца с неизмененными и малоизмененными коронарными артериями. Кардиология, 1999. 39(№ 1): р. 25−30.
- Сергиенко, В.Б., С.П. Паша, and Н. И. Ахмеджанов, Увеличение захвата таллия-201 при пробе с дипиридамолом у больных со стенокардией при неизмененных коронарограммах. Мед. радиол., 1990. № 9: р. 10−14.
- Matsunari, I., et al., Myocardial viability assessment using nuclear imaging. Ann Nucl Med, 2003. 17(3): p. 169−79.
- Лишманов, Ю.Б. and В. И. Чернов, Сцинтиграфия миокарда в ядерной кардиологии. Vol. 276 с. 1997, Томск.
- Cannon, R.O., 3rd, et al., Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J Am Coll Cardiol, 1987. 10(6): p. 1190−200.
- Gill, J.В., et al., Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med, 1987. 317(24): p. 1486−9.
- Iskandrian, A.S., A.H. Hakki, and S. Kane-Marsch, Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease. Am Heart J, 1985. 110(1 Pt 1): p. 135−43.
- Iskandrian, A.S., et al., Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol, 1988. 61(4): p. 269−72.
- Travin, M.I., et al., Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol, 1995. 75(10): p. 665−9.
- Miller, T.D., et al., Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. Am J Cardiol, 1998. 81(12): p. 1491−3.
- Elhendy, A., et al., Differential prognostic significance of peri-infarction versus remote myocardial ischemia on stress technetium-99m sestamibi tomography in patients with healed myocardial infarction. Am J Cardiol, 2004. 94(3): p. 289−93.
- Dorbala, S., et al., Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med, 2007. 48(3): p. 349−58.
- Abidov, A., G. Germano, and D.S. Berman, Transient ischemic dilation ratio: a universal high-risk diagnostic marker in myocardial perfusion imaging. J Nucl Cardiol, 2007. 14(4): p. 497−500.
- Leslie, W.D., D.P. Levin, and S.J. Demeter, Variation in heart rate influences the assessment of transient ischemic dilation in myocardial perfusion scintigraphy. BMC Nucl Med, 2007. 7: p. 1.
- Valdiviezo, C., et al., The significance of transient ischemic dilation in the setting of otherwise normal SPECT radionuclide myocardial perfusion images. J Nucl Cardiol, 2011.18(2): p. 220−9.
- Hida, S., et al., Postischemic Myocardial Stunning Is Superior to Transient Ischemic Dilation for Detecting Multivessel Coronary Artery Disease. Circ J, 2011.
- Muzzarelli, S., et al., Interrelation of ST-segment depression during bicycle ergometry and extent of myocardial ischaemia by myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging, 2009. 36(11): p. 1842−50.
- Momose, M., et al., Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Med Mol Imaging, 2009. 36(8): p. 1315−21.
- Groothuis, J.G., et al., Low to intermediate probability of coronary artery disease: comparison of coronary CT angiography with first-pass MR myocardial perfusion imaging. Radiology, 2010. 254(2): p. 384−92.
- Schuijf, J.D., et al., Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol, 2006. 48(12): p. 2508−14.
- Scholte, A.J., C.J. Roos, and J.M. van Werkhoven, Function and anatomy: SPECT-MPI and MSCT coronary angiography. Eurolntervention, 2010. 6 Suppl G: p. G94-G100.
- Berman, D.S., et al., Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol, 2007. 14(4): p. 521−8.
- Osbakken, M.D., et al., Comparison of exercise perfusion and ventricular function imaging: an analysis of factors affecting the diagnostic accuracy of each technique. J Am Coll Cardiol, 1984. 3(2 Pt 1): p. 272−83.
- Friedman, T.D., et al., Exercise thallium-201 myocardial scintigraphy in women: correlation with coronary arteriography. Am J Cardiol, 1982. 49(7): p. 1632−7.
- Dilsizian, V. and R.O. Bonow, Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation, 1993. 87(1): p. 1−20.
- Charney, R., et al., Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J, 1994. 128(5): p. 864−9.
- Mori, T., et al., Rest-injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med, 1991.32(9): p. 1718−24.
- Udelson, J.E., et al., Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201 Tl and 99mTc-sestamibi. Circulation, 1994. 89(6): p. 2552−61.
- Rocco, T.P., et al., Comparison of thallium redistribution with rest «reinjection» imaging for the detection of viable myocardium. Am J Cardiol, 1990. 66(2): p. 158−63.
- Kayden, D.S., et al., Thallium-201 for assessment of myocardial viability: quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. J Am Coll Cardiol, 1991.18(6): p. 1480−6.
- Dilsizian, V., et al., Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation, 1992. 85(2): p. 627−34.
- Udelson, J.E., Choosing a thallium-201 or technetium 99m sestamibi imaging protocol. J Nucl Cardiol, 1994. 1(5 Pt 2): p. S99−108.
- Iskandrian, A.S., Thallium reinjection imaging: the search for an optimal protocol. J Nucl Med, 1993. 34(5): p. 743−6.
- Lebowitz, E., et al., Thallium-201 for medical use. I. J Nucl Med, 1975. 16(2): p. 151−5.
- Gunel, S.E. and A. Akgun, Comparison of exercise-rest-reinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability. Ann Nucl Med, 2009. 23(5): p. 451−7.
- Boucher, C.A., Detection and location of myocardial infarction using technetium-99m sestamibi imaging at rest. Am J Cardiol, 1990. 66(13): p. 32E-35E.
- Hurrell, D.G., et al., Acute myocardial infarction followed by technetium-99m-sestamibi SPECT imaging and pathologic correlation. J Nucl Med, 1997. 38(12): p. 1837−40.
- Сергиенко, В.Б., et al., Экспериментальные исследования 99тТс-МИБИ для перфузионной сцинтиграфии миокарда, in Всесоюзный кардиологический научный центр АМН СССР. 1991: Москва.
- Carvalho, P.A., et al., Subcellular distribution and analysis of technetium-99m-MIBl in isolated perfused rat hearts. J Nucl Med, 1992. 33(8): p. 1516−22.
- Chiu, M.L., J.F. Kronauge, and D. Piwnica-Worms, Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med, 1990.31(10): p. 1646−53.
- De Coster, P.M., et al., Technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental myocardial infarction. Circulation 1990. 82: p. 2152−62.
- De Coster, P.M., et al., Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation, 1990. 82(6): p. 2152−62.
- Freeman, I., et al., Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med, 1991. 32(2): p. 292−8.
- Glover, D.K. and R.D. Okada, Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation, 1990. 81(2): p. 628−37.
- Maublant, J.C., P. Gachon, and N. Moins, Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J Nucl Med, 1988. 29(1): p. 48−54.
- Meerdink, D.J. and J. A. Leppo, Comparison of hypoxia and ouabain effects on the myocardial uptake kinetics of technetium-99m hexakis 2-methoxyisobutyl isonitrile and thallium-201. J Nucl Med, 1989. 30(9): p. 1500−6.
- Piwnica-Worms, D., et al., Effect of metabolic inhibition on technetium-99m-MIBl kinetics in cultured chick myocardial cells. J Nucl Med, 1990. 31(4): p. 464−72.
- Okada, R.D., et al., Technetium-99m sestamibi kinetics in reperfused canine myocardium. Eur J Nucl Med, 1995. 22(7): p. 600−7.
- Fujiwara, Y., et al., Quantitative analysis of acute myocardial infarction using single photon emission computed tomography using technetium-99m pyrophosphate. J Cardiogr, 1986. 16(3): p. 555−62.
- Becker, L.C., Technetium-99m isonitrile tomography in patients with acute myocardial infarction: measurement of myocardial salvage by thrombolysis. J Am Coll Cardiol, 1990.15(2): p. 315−7.
- Gibbons, R.J., Technetium 99m sestamibi in the assessment of acute myocardial infarction. Semin Nucl Med, 1991.21(3): p. 213−22.
- Botvinick, E.H., et al., Noninvasive quantitation of myocardial infarction with technetium 99m pyrophosphate. Circulation, 1975. 52(5): p. 909−15.
- McLaughlin, P., et al., Detection of acute myocardial infarction by technetium-99m polyphosphate. Am J Cardiol, 1975.35(3): p. 390−6.
- Willerson, J.T., et al., Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams. Circulation, 1975. 51(3): p. 436−41.
- Werner, J.A., et al., Acute myocardial infarction: clinical application of technetium 99m stannous pyrophosphate infarct scintigraphy. West J Med, 1977.127(6): p. 464−78.
- Walsh, W.F., et al., Assessment of diagnostic value of technetium-99m pyrophosphate myocardial scintigraphy in 80 patients with possible acute myocardial infarction. Br Heart J, 1977. 39(9): p. 974−81.
- Cowley, M.J., et al., Technetium-99m stannous pyrophosphate myocardial scintigraphy. Reliability and limitations in assessment of acute myocardial infarction. Circulation, 1977. 56(2): p. 192−8.
- Arrigo, F., et al., Cardiac scintigraphy with technetium 99m pyrophosphate in the diagnosis of a focus of acute myocardial infarction. Boll Soc Ital Cardiol, 1981. 26(6): p. 527−37.
- Tamaki, S., et al., Emission computed tomography with technetium-99m pyrophosphate for delineating location and size of acute myocardial infarction in man. Br Heart J, 1984. 52(1): p. 30−7.
- Rosano, J.P., J. Silvestre, and J.M. Vinot, Myocardial tomoscintigraphy with technetium pyrophosphate in the diagnosis of recent infarction. Arch Mai Coeur Vaiss, 1984. 77(3): p. 301−6.
- Nakashima, Y., et al., Clinical significance of persistently positive technetium-99m pyrophosphate myocardial scintigrams in patients with acute myocardial infarction., Kaku Igaku, 1984. 21(3): p. 221−9.
- Desai, A.G., et al., Technetium-99m pyrophosphate scintigraphy for the detection of acute myocardial infarction. How useful is it? Clin Nucl Med, 1985. 10(9): p. 622−5.
- Onishi, Т., et al., Evaluating microvascular obstruction after acute myocardial infarction using cardiac magnetic resonance imaging and 201-thallium and 99m-technetium pyrophosphate scintigraphy. Circ J, 2010. 74(12): p. 2633−40.
- Miller, T.D., R. Sciagra, and R.J. Gibbons, Application of technetium-99m sestamibi single photon emission computed tomography in acute myocardial infarction: measuring the efficacy of therapy. Q J Nucl Med Mol Imaging, 2010. 54(2): p. 213−29.
- Cuocolo, A., et al., Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med, 1992.33(4): p. 505−11.
- Maublant, J.C., et al., Rest technetium 99m-sestamibi tomoscintigraphy in hibernating myocardium. Am Heart J, 1995.129(2): p. 306−14.
- Bisi, G., et al., Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med, 1995. 36(11): p. 1994−2000.
- Hendel, R.C., et al., Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium 201 and technetium 99m-labeled tetrofosmin. J Nucl Cardiol, 1994.1(6): p. 509−14.
- Самойленко, JI.E., Перфузионная сцинтиграфия миокарда в клинической кардиологии. Дис.. д-ра мед. наук, 1997.
- Bengel, F.M., et al., Cardiac positron emission tomography. J Am Coll Cardiol, 2009. 54(1): p. 1−15.
- Knesaurek, K., et al., Comparison of 2-dimensional and 3-dimensional 82Rb myocardial perfusion PET imaging. J Nucl Med, 2003. 44(8): p. 1350−6.
- Gropler, R.J., et al., Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol, 1993. 22(6): p. 1587−97.
- Maddahi, J., et al., Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med, 1994. 35(4): p. 70 715.
- Duvernoy, C.S., et al., The role of nitrogen 13 ammonia positron emission tomography in predicting functional outcome after coronary revascularization. J Nucl Cardiol, 1995. 2(6): p. 499−506.
- Tamaki, N., et al., Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med, 1991. 32(4): p. 673−8.
- Marwick, T.H., et al., Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism. Circulation, 1992. 85(4): p. 1347−53.
- Einstein, A.J., et al., Radiation dose to patients from cardiac diagnostic imaging. Circulation, 2007.116(11): p. 1290−305.
- Bateman, T.M., et al., Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol, 2006.13(1): p. 24−33.
- Yoshinaga, K., et al., What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol, 2006. 48(5): p. 1029−39.
- Merhige, M.E., et al., Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med, 2007. 48(7): p. 1069−76.
- Massoud, T.F. and S.S. Gambhir, Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev, 2003. 17(5): p. 545−80.
- Knaapen, P., et al., Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Neth Heart J, 2010.18(2): p. 90−8.
- Rudd, J.H., et al., Imaging atherosclerotic plaque inflammation with 18 °F.-fluorodeoxyglucose positron emission tomography. Circulation, 2002.105(23): p. 2708−11.
- Nahrendorf, M., et al., Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation, 2008.117(3): p. 379−87.
- Delbeke, D., et al., Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med, 2009.39(5): p. 308−40.
- Min, J.K., et al., Costs and clinical outcomes after coronary multidetector CT angiography in patients without known coronary artery disease: comparison to myocardial perfusion SPECT. Radiology, 2008. 249(1): p. 62−70.
- Goldstein, J.A., et al., A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol, 2007. 49(8): p. 863−71.
- Naghavi, M., et al., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation, 2003.108(15): p. 1772−8.
- Chen, J., et al., In vivo imaging of proteolytic activity in atherosclerosis. Circulation, 2002. 105(23): p. 276 671.
- Kelly, K.A., et al., Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res, 2005. 96(3): p. 327−36.
- Kietselaer, B.L., et al., Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med, 2004. 350(14): p. 1472−3.
- Winter, P.M., et al., Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v)beta3-integrin-targetednanoparticles. Circulation, 2003. 108(18): p. 2270−4.
- Matter, C.M., et al., Molecular imaging of atherosclerotic plaques using a human antibody against the extradomain B offlbronectin. Circ Res, 2004. 95(12): p. 1225−33.
- Hofstra, L., et al., Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet, 2000. 356(9225): p. 209−12.
- Narula, J., et al., Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med, 2001. 7(12): p. 1347−52.
- Libby, P., Inflammation in atherosclerosis. Nature, 2002. 420(6917): p. 868−74.
- Weissleder, R., et al., In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol, 1999. 17(4): p. 375−8.
- Tung, C.H., et al., In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res, 2000. 60(17): p. 4953−8.
- Bremer, C., C.H. Tung, and R. Weissleder, In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med, 2001. 7(6): p. 743−8.
- Ohshima, S., et al., Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor. J Nucl Med, 2009. 50(4): p. 612−7.
- Jaffer, F.A., et al., In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vase Biol, 2002. 22(11): p. 1929−35.
- Ntziachristos, V., C. Bremer, and R. Weissleder, Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol, 2003.13(1): p. 195−208.
- Занесений, B.H. and О. Б. Дынник, Молекулярная визуализация в медицины, проблемы и перспективы. Украинский медицинский журнал 2005. 2 (46): р. 76−83.
- Germano, G., Р.В. Kavanagh, and D.S. Berman, An automatic approach to the analysis, quantitation and review ofperfusion andfunction from myocardial perfusion SPECT images. Int J Card Imaging, 1997.13(4): p. 337−46.
- Germano, G., et al., Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. J Nucl Med, 1995. 36(6): p. 1107−14.
- Germano, G., et al., A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med, 2000. 41(4): p. 712−9.
- Knollmann, D., et al., Comparison of SSS and SRS calculated from normal databases provided by QPS and 4D-MSPECT manufacturers and from identical institutional normals. Eur J Nucl Med Mol Imaging, 2008. 35(2): p. 311−8.
- Kellman, P., et al., Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med, 2002. 47(2): p. 372−83.
- Caracciolo, E.A., et al., Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation, 1995. 91(9): p. 2335−44.
- Yusuf, S., et al., Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet, 1994. 344(8922): p. 563−70.
- Jeremias, A., et al., The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med, 2009. 122(2): p. 152−61.
- Serruys, P.W., et al., Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009. 360(10): p. 961−72.
- Tanigawa, Т., et al., Influence of diabetes mellitus on the initial and long-term outcome of patients treated with coronary stentingj. J Cardiol, 2002. 39(3): p. 133−40.
- Murphy, K.J., J.A. Brunberg, and R.H. Cohan, Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol, 1996. 167(4): p. 847−9.
- Canavese, C., et al., Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. J Nephrol, 2008. 21(3): p. 324−36.
- Cacheris, W.P., S.C. Quay, and S.M. Rocklage, The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging, 1990. 8(4): p. 467−81.
- Ishida, M., S. Kato, and H. Sakuma, Cardiac MRI in ischemic heart disease. Circ J, 2009. 73(9): p. 1577−88.
- Грамович, В.В., et al., Количественная оценка перфузии миокарда с помощью магнитно резонансной томографии у больных хронической ишемической болезнью сердца. Кардиология, 2004. 44(8): р. 4−12.
- Cho, S. and M.V. McConnell, Echocardiographic and magnetic resonance methods for diagnosing hibernating myocardium. Nucl Med Commun, 2002. 23(4): p. 331−9.
- Bremerich, J., et al., Noninvasive stress testing of myocardial ischemia: comparison of GRE-MRI perfusion and wall motion analysis to 99 mTc-MIBI-SPECT, relation to coronary angiography. Eur Radiol, 1997. 7(7): p. 990−5.
- Gupta, V., et al., Fully automatic registration and segmentation of first-pass myocardial perfusion MR image sequences. Acad Radiol, 2010. 17(11): p. 1375−85.
- Schuetz, G.M., et al., Meta-analysis: noninvasive coronary angiography using computed tomography versus magnetic resonance imaging. Ann Intern Med, 2010. 152(3): p. 167−77.
- Mastouri, R., S.G. Sawada, and J. Mahenthiran, Current noninvasive imaging techniques for detection of coronary artery disease. Expert Rev Cardiovasc Ther, 2010. 8(1): p. 77−91.
- Beckmann, S., et al., Diagnosis of coronary artery disease and viable myocardium by stress echocardiography. Diagnostic accuracy of different stress modalities. Eur Heart J, 1995. 16 Suppl J: p. 10−8.
- Di Carli, M.F., et al., Clinical myocardial perfusion PET/CT. J Nucl Med, 2007. 48(5): p. 783−93.
- Dorbala, S., et al., Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging, 2009. 2(7): p. 846−54.
- Marwick, Т.Н., et al., Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am J Cardiol, 1997. 80(7): p. 865−70.
- Покровский, В.И., Энциклопедический словарь медицинских терминов. 2005: M.